Página 3 - Melhores Linfoma médicos - TOP-91 médicos

Médico-chefe no centro de oncologia do BKZ Solingen – O Dr. Fox lidera a melhor equipe da Alemanha para o tratamento de linfoma com terapias inovadoras.

• Especialista em hematologia, oncologia e imunologia desde 2011
• Pioneiro em diagnósticos moleculares e terapias direcionadas
• Pesquisador ativo em tratamentos de doenças hemato-oncológicas
• Membro da American Association for Cancer Research
• Especialista qualificado em genética desde 2016

O Prof. Dr. Hasan Atilla Ozkan lidera a Associação Turca de Aférese Terapêutica e é especializado no tratamento de linfoma no Hospital VM Medical Park Pendik.

• Mais de 20 anos de experiência em hematologia e medicina interna
• Certificado em transplante de células estaminais autólogas e alogénicas
• Membro da EBMT (European Society for Blood and Marrow Transplantation)
• Vencedor do Young Researcher Award 2011 em Aférese Terapêutica

O Professor Drach liderou o programa de Mieloma Múltiplo e Linfoma Maligno num dos maiores hospitais públicos da Europa – o Hospital Geral de Viena (AKH).

• Mais de 20 anos de experiência especializada em medicina interna e oncologia
• Realizar uma bolsa de investigação no M.D. Anderson Cancer Center, nos EUA
• Publicar mais de 120 artigos científicos sobre cancros hematológicos
• Atual Diretor da Clínica Privada Josefstadt, em Viena
• Membro do conselho da Sociedade Austríaca de Hematologia e Oncologia

O Dr. Eckhart Weidmann é especialista em linfoma não-Hodgkin, com mais de 900 procedimentos realizados como chefe de hematologia na Clínica Nordwest.

• 34 anos de experiência em oncologia e onco-hematologia
• Professor e chefe do Departamento de Hematologia
• Realizou mais de 1.100 procedimentos em sua carreira
• Especialista em tratamentos de distúrbios sanguíneos

Reconhecido como um dos melhores médicos de Israel pela Forbes em 2019-2020, o Dr. Gal Goldstein é o Chefe de Oncologia Pediátrica do Hospital Hadassah.

• Especializar-se exclusivamente em hemato-oncologia pediátrica há mais de 20 anos
• Especialista em tratamentos avançados, como transplantes de medula óssea haploidentificos
• Foco profundo em cancros infantis específicos, incluindo o retinoblastoma
• Membro ativo de sociedades internacionais de oncologia, como a SIOP
• Empregar medicina de precisão para personalizar planos de tratamento

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

O Professor Bosch é um líder de renome mundial na investigação da Leucemia Linfocítica Crónica (LLC) e linfoma, com mais de 80 ensaios clínicos em curso.

• Especializar-se em linfomas e leucemia linfocítica crónica com abordagens de tratamento inovadoras
• Presidente do grupo espanhol para o estudo da LLC (GELLC)
• Diretor de Hematologia do IOB Instituto de Oncologia e do Hospital Universitário Vall d'Hebron
• Publicar mais de 100 artigos nas principais revistas médicas, incluindo NEJM e Nature Medicine

Especializa-se exclusivamente em linfoma, concentrando a sua prática neste cancro do sangue complexo no Rambam Medical Center.

• Hematologista com profunda experiência em subtipos de linfoma
• Fornecer tratamentos direcionados para esta condição específica
• Sediado num prestigiado hospital de investigação e cuidados terciários

Karen Drumea é especialista em radioterapia oncológica, focando-se no tratamento de pacientes com câncer através de radiação no Rambam Medical Center.

• Anos de experiência em rádio-oncologia e oncologia geral
• Especialização no uso de radioterapia para tratar cânceres
• Sediada no Rambam Medical Center em Israel
• Combinação de experiência em oncologia radioterápica e médica para o atendimento ao paciente

O Professor Zuckerman especializa-se exclusivamente em hematologia e transplante de células estaminais para linfoma no Rambam Medical Center.

• Mais de 25 anos de experiência em hematologia e medicina de transplante
• Focar no transplante de medula óssea e de células estaminais para doentes com linfoma
• Atuar como médico sénior e professor no Rambam Medical Center
• Especialização em casos complexos que exigem protocolos de transplante avançados